Rituximab therapy reduces organ-specific T cell responses and ameliorates experimental autoimmune encephalomyelitis (Q33832088)

29 July 2017

Rituximab therapy reduces organ-specific T cell responses and ameliorates experimental autoimmune encephalomyelitis (English)

1 reference

experimental autoimmune encephalomyelitis

29 July 2017

0 references

1 reference

Anne H Cross

11

0 references

Olaf Stüve

13

object named as

Olaf Stüve

1 reference

29 July 2017

Nancy L Monson

1

1 reference

29 July 2017

Petra Cravens

2

1 reference

29 July 2017

Rehana Hussain

3

1 reference

29 July 2017

Christopher T Harp

4

1 reference

29 July 2017

Matthew Cummings

5

1 reference

29 July 2017

Maria de Pilar Martin

6

1 reference

29 July 2017

Li-Hong Ben

7

1 reference

29 July 2017

Julie Do

8

1 reference

29 July 2017

Jeri-Anne Lyons

9

1 reference

29 July 2017

Amy Lovette-Racke

10

1 reference

29 July 2017

Michael K Racke

12

1 reference

29 July 2017

Mark Shlomchik

14

1 reference

29 July 2017

Todd N Eagar

15

1 reference

29 July 2017

language of work or name

English

0 references

publication date

16 February 2011

1 reference

29 July 2017

1 reference

29 July 2017

6

1 reference

29 July 2017

2

1 reference

29 July 2017

e17103

1 reference

Memory B cells from a subset of treatment-naïve relapsing-remitting multiple sclerosis patients elicit CD4(+) T-cell proliferation and IFN-γ production in response to myelin basic protein and myelin oligodendrocyte glycoprotein

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3040191

B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3040191

Disease-modifying agents for multiple sclerosis: recent advances and future prospects

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3040191

Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3040191

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3040191

Potential role of humoral immunity in the pathogenesis of multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE).

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3040191

Novel approaches and cutting edge immunotherapies in multiple sclerosis

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3040191

B cells regulate autoimmunity by provision of IL-10.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3040191

Rituximab: ongoing and future clinical development

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3040191

Molecular cloning of the human B cell CD20 receptor predicts a hydrophobic protein with multiple transmembrane domains

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3040191

CTLA-4 regulates expansion and differentiation of Th1 cells following induction of peripheral T cell tolerance.

4 July 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0017103

Decrease in the numbers of dendritic cells and CD4+ T cells in cerebral perivascular spaces due to natalizumab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0017103

Distinct profiles of human B cell effector cytokines: a role in immune regulation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0017103

Surface phenotype and function of tonsillar germinal center and mantle zone B cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0017103

The role of CTLA-4 in induction and maintenance of peripheral T cell tolerance

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3040191

Monoclonal antibody 1F5 (anti-CD20) serotherapy of human B cell lymphomas

29 October 2018

1 reference

12 December 2020

Delayed type hypersensitivity (DTH) in anti-IgM-treated B cell-depleted mice: analysis of induction and effector phase

1 reference

12 December 2020

Clinical stabilization and effective B-lymphocyte depletion in the cerebrospinal fluid and peripheral blood of a patient with fulminant relapsing-remitting multiple sclerosis

1 reference

12 December 2020

B cell regulation of CD4+CD25+ T regulatory cells and IL-10 via B7 is essential for recovery from experimental autoimmune encephalomyelitis

1 reference

12 December 2020

Depletion of B cells in murine lupus: efficacy and resistance

1 reference

12 December 2020

B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide

1 reference

12 December 2020

No clinical evidence for CD4+ cell depletion caused by rituximab

1 reference

12 December 2020

10.1371/JOURNAL.PONE.0017103

Identifiers

DOI

1 reference

29 July 2017

0 references

1 reference

29 July 2017

1 reference